SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (33)2/12/1999 6:54:00 AM
From: Henry Niman  Read Replies (1) of 438
 
WSJ and NY Times have extensive articles on ENMD this morning. Both have a note of caution about translating animal work to humans as well as the volatility of the molecules. However both discuss the NCI start of clinical trials this fall and the NY Times indicates that production of 2 pounds of Endostatin has been out-sourced. Details linked to Anti-Angiogenesis table in New Therapeutics section of biocognizance.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News